Mouth sores and daily life in head and neck cancer patients after radiotherapy
Looks back at mouth sores in adults treated with radiotherapy for head and neck cancer.
Plain-language title generated from the registry record
Registry title: Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.
Key facts
- Where
- Madrid, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with head and neck cancer who had radiotherapy or chemoradiotherapy between 2019 and 2023. It reviews their past medical records for mouth sores.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Head and neck cancer. The record names no stage.
- Earlier treatment
- Radiotherapy or chemoradiotherapy between 2019 and 2023, with or without surgery and/or immunotherapy. They must have used topical care for the lining of the mouth.
Main reasons for not taking part
- Missing or incomplete medical records needed for the study
- Another cancer under active treatment at the same time
Read by machine on 12 November 2026.
Where in Spain
- Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara CampalMadrid, SpainContact: Mariola García-Aranda Pez, MDNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mucosa Innovations, S.L.
- Trial code
- NCT07739771
- Record updated
- 31 July 2026
- Original description
Head and Neck cancer patients receiving radiation therapy (with or without chemotherapy) suffer several oral complications, such as oral mucositis, which impairs quality of life of patients during radiotherapy and in the post-treatment follow-up period. The use of topical agents to protect oral mucosa against radiation-induced toxicity is part of the routine clinical practice. Among these products, the use of mouthwashes and/or gels are extensively used in the Centro Oncológico Clara Campal - Hospital HM Sanchinarro. Once such product is a proprietary formulation based on natural ingredients such as olive oil, betaine, and xylitol (Mucosa Innovations S.L.).Read full original descriptionShow less
Retrospective Evaluation of Severe Oral Mucositis Incidence, Time to Onset and Functional Impact in Quality of Life in Head and Neck Cancer Radiated and Chemo-radiated Patients. Part of the Stop Oral Mucositis Project (STOPOMP)
Head and Neck cancer patients receiving radiation therapy (with or without chemotherapy) suffer several oral complications, such as oral mucositis, which impairs quality of life of patients during radiotherapy and in the post-treatment follow-up period. The use of topical agents to protect oral mucosa against radiation-induced toxicity is part of the routine clinical practice. Among these products, the use of mouthwashes and/or gels are extensively used in the Centro Oncológico Clara Campal - Hospital HM Sanchinarro. Once such product is a proprietary formulation based on natural ingredients such as olive oil, betaine, and xylitol (Mucosa Innovations S.L.).
Inclusion: Adults (≥18 years) diagnosed with head and neck cancer; Treated with radiotherapy or chemoradiotherapy, with or without surgery and/or immunotherapy, according to tumor type and stage, between 2019 and 2023; With available medical records documenting clinical assessments of oral mucositis during at least the radiotherapy/CRT treatment period, and that had used the oral mucosa topical measures.
Exclusion: Patients with concomitant malignancies undergoing active treatment at the same time; Patients with missing or insufficient clinical records required for the study.